Lin et al. [10] documented that when comparing the expression of s-DAPK-1 mRNA in cancerous cells (HCT116 and A375) and non-cancerous cells (HEK-293), s-DAPK-1 was highly expressed in HEK-293 (5.517-fold change) relative to HCT116 (0.000-fold change) and A375 (0.455-fold change) cells, indicating that s-DAPK-1 could potentially serve as an antitumor protein, particularly in the cases of skin and colorectal cancer. The gene discussed is DAPK1; the disease is colorectal cancer.